Yes, marketing and brand awareness of our innovations are exactly what we need at this stage of our roadmap. It set up well leading to FDA approval of clinical trial and later PMA.
I noticed JenaValve seems to be having some good social marketing and support but it doesn’t seem to have the same level of innovations and life saving benefits to the patients as much as we do.
Not Advice, DYOR!
AVR already up on the big stage at TVT22 - we have “arrived”!, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |